Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cell Reports|May 7, 2013
Chromosomal instability triggered by Rrm2b loss leads to IL-6 secretion and plasmacytic neoplasmsLufen Chang, Robin Guo, Qin Huang, et al.Nature Reviews. Clinical Oncology|June 10, 2020
MET-dependent solid tumours - molecular diagnosis and targeted therapyRobin Guo, Jia Luo, Jason Chang, et al.Cancer Treatment Reviews|September 15, 2022
Refining patient selection of MET-activated non-small cell lung cancer through biomarker precisionGillianne G Y Lai, Robin Guo, Alexander Drilon, et al.British Journal of Haematology|November 17, 2017
Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicitiesRichard J Lin, Helen Ma, Robin Guo, et al.Proceedings of the National Academy of Sciences of the United States of America|November 19, 2008
ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damageLufen Chang, Bingsen Zhou, Shuya Hu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2019
Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural MesotheliomasRobin Guo, Mariel DuBoff, Gowtham Jayakumaran, et al.Lung Cancer (Amsterdam, Netherlands)|October 16, 2021
Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancersMartin Gutierrez, Robin Guo, Giuseppe Giaccone, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2019
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation ConsortiumRobin Guo, Lynne D Berry, Dara L Aisner, et al.JCO Precision Oncology|September 14, 2020
CNS Metastases in Patients With <i>MET</i> Exon 14-Altered Lung Cancers and Outcomes With CrizotinibMichael Offin, Jia Luo, Robin Guo, et al.Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.Pageof 2